1.Based on DCF valuation techniques, what range of values is reasonable for Genentech as a stand-alone company in June 2008?Please exclude synergies from your valuation and use a 9% weighted average cost of capital.You can assume that as of the end of June 2008, Genentech held approximately $7 billion in cash, which included investments and securities that were not needed in its daily operations.(Exhibit 10 is a good starting point for this analysis)

Answer rating: 100% (QA)

To determine the reasonable range of values for Genentech as a standalone company in June 2008 using ... View the full answer